Approval · Notice of Compliance 15290 · 2014
TARO-TESTOSTERONE: Notice of Compliance 15290
Issued February 19, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15290
- Date
- February 19, 2014
- Company
- Taro Pharmaceuticals IncBrampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Adrogen
- Canadian reference product
- ANDRIOL (Organon Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TARO-TESTOSTERONE | 02421186 | Marketed |
Medicinal ingredients
- TESTOSTERONE UNDECANOATE 40 MG per CAP